What is the clinical value of ultra-long-acting insulin?

Currently, basal insulin requires daily injections to maintain a steady level of glucose control. Once-weekly insulins utilize novel molecular engineering to extend the half-life of the protein, allowing for a single weekly dose. This innovation addresses the "burden of care" which is the leading cause of treatment inertia among patients.

How will Once-Weekly Insulin Adoption affect 2024 market dynamics?

The potential for Once-Weekly Insulin Adoption is high, particularly in the geriatric population. In 2024, as late-stage trials publish results, the strategic focus for pharma companies is on "switching studies"—demonstrating that patients can transition from daily to weekly regimens safely without increasing the risk of nocturnal hypoglycemia.

What are the 2025 competitive implications?

By 2025, once-weekly insulin could cannibalize a significant portion of the daily basal market. This creates a high-stakes competition between the two or three primary leaders in insulin manufacturing. The winner will likely be the company that can bundle the weekly insulin with a smart-pen that tracks doses and provides injection site rotation reminders.

• Reduction in injection-related anxiety and site lipohypertrophy.
• Improved health-related quality of life (HRQoL) metrics.
• Simpler co-administration with once-weekly GLP-1s.

2025 Market Outlook

The 2025 outlook indicates that once-weekly insulins will become the preferred choice for primary care physicians. We anticipate a rapid shift in treatment guidelines to reflect this preference, provided that the pricing remains competitive with daily analogs.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com